|
第1天:2012年2月12日,星期日 |
|
4th International Conference on
Drug
Discovery & Therapy
February 12– 15, 2012,
Dubai Men’s College, Dubai, UAE
|
|
|
INAUGURAL PROGRAM |
|
|
|
COFFEE
BREAK: 11:00 – 11:45 a.m. |
|
PLENARY SESSION |
|
Time |
Chairman: R. Huber
Co-Chairman:
H. zur Hausen
|
Speaker |
Title |
|
11:45
12:30 p.m. |
Location:
Auditorium |
Hartmut Michel (Nobel Laureate)
PL-1 |
Membrane
Proteins: importance, functions, structures |
|
12:30
01:15 p.m. |
Location:
Auditorium |
Mario
Molina (Nobel Laureate)
PL-2 |
Climate Change: Science, Policy and Solutions |
|
01:15
02:00 p.m. |
Location:
Auditorium |
Muhammad Iqbal Choudhary
PL-3 |
Cost Effective Lead Discovery from Natural Products |
|
LUNCH
BREAK: 2:00 – 3:15 p.m. |
|
|
Lecture Hall
1
(L-115) |
Lecture Hall 2
(B-121) |
Hall No. 3
(B-250) |
Hall No. 4
(C-106) |
Hall No. 5
(B-116) |
|
|
Regenerative Medicine |
CNS Drug Discovery & Therapy |
Hot Topics in Natural Products |
Hot Topics in Drug Targets |
Anti-Cancer Drug Discovery & Therapy |
|
|
Chairman:
C. Prakash
Co-Chairman:
Suresh Balan |
Chairman:
A.Koito
Co-Chairman:
H, Ohrui |
Chairman:
T. Elbayoumi
Co-Chairman:
D.P. Ramji |
Chairman:
M. J. Korbling
Co-Chairman: L. X. Tiefenauer |
Chairman: D.K. Lahiri
Co-Chairman:
W. B. Weglicki |
|
03:15
03:45
p.m. |
Antonio
Claudio Tedesco
IL-4
Evaluation
of Advanced Nanomatrial to Controlled Release of
Photoactive Compounds under Skin Dermal Equivalent to improve Wound Healing
and Burning Treatment of Skin Disorder in Tissue Engineering |
03:15
03:45
p.m. |
Hideaki Itoh
IL-5
Cisplatin,
A HSP90 Inhibitor
|
03:15
03:45
p.m. |
Tushar
Kanti Chakraborty
IL-6
Challenges
in Drug Discovery – from Natural Products to Designer Molecules |
03:15
03:45
p.m. |
Ewa
Skrzypczak-Jankun
IL-7
Human
Lipoxygenase: Structure, Function, Relevance to
Human Diseases and Challenges in Drug Development |
03:15
03:45
p.m. |
Ola
Larsson
IL-8
Perturbation
of the Translatome by the Anti-Diabetic Drug
Metformin |
|
03:45
04:15
p.m. |
Marcelo
Einicker Lamas
IL-9
Crosstalk
Between Bone Marrow-Derived Stem Cells and Renal Epithelial Cells: Effects on
Cell Death and Proliferation as a Perspective for Cell-based Therapies for
Nephropathies |
03:45
04:15
p.m. |
Yoshiyuki
Suzuki
IL-10
Chemical
Chaperone Therapy for Neuronopathic Lysosomal Diseases |
03:45
04:15
p.m. |
Srivari
Chandrasekhar
IL-11
Approaches
for the Total Synthesis of Marine Natural Products as Leads in
Pharmaceuticals |
03:45
04:15
p.m. |
Walid
A. Houry
IL-12
Activators
of Cylindrical Proteases as Antimicrobials: Identification and Development of
Novel Small Molecule Activators of the ClpP
Protease
|
03:45
04:05
p.m. |
Elie Hadchity
SL-13
Peptide
Aptamers, Inhibitors of Hsp27: New Therapeutic
Agents |
|
04:15
04:45
p.m. |
Aris
Lacis
IL-14
Three
Years Experience of Using Stem Cells Therapy for Heart Failure and Pulmonary
Hypertension in Children |
04:15
04:45
p.m. |
Messoud Ashina
IL-15
The
PACAP Receptor: A Novel Target for Migraine Treatment |
04:15
04:35
p.m. |
Mohammadmehdi
Fani
SL-16
Inhibitory Activity of
Cinnamon Zeylanicum and Eucalyptus Globulus Oils on Streptococcus mutans,
Staphylococcus aureus, and Candida species Isolated
from Pateiens with Oral Infections |
04:15
04:45
p.m. |
Debomoy
K. Lahiri
IL-17
MicroRNA
to Study Physiological Regulation of Gene Products Implicated in CNS
Disorders: Discovery of Novel APP and BACE-specific MicroRNAs Important for
Alzheimer’s Disease |
04:05
04:25
p.m. |
Shirley
Knauer
SL-18
Induction
of Tumor Cell Death by Survivin Nuclear Export
Inhibitors |
|
04:45
05:15
p.m. |
Stephen
J. Faulkner
IL-19
A
Prospective Case Series of Patients Treated with Adult Autologous, Culture
Expanded Mesenchymal Stem Cells for Symptomatic
Osteoarthritic Hip and Knee Joints Compared to an Untreated Comparison Group |
04:45
05:05
p.m. |
Mehmet
Ozbilen
SL-20
Systematic
Overview of Cochrane Reviews for Anticholinergic Effects of Antipsychotic
Drugs
|
04:35
04:55
p.m. |
Basiouny
El-Gamal
SL-21
Beneficial
Effects of Omega-3 Fatty Acid Dietary Supplementation in Patients with
Systemic Lupus Erythematosus |
04:45
05:15
p.m. |
Wael
M. ElShamy (2)
IL-22
BRCA1-IRIS
Overexpression Promotes Formation of TN/BL Aggressive Breast Cancers |
04:25
04:45
p.m. |
Mu
Wang
SL-23
Superoxide
Dismutase 1 as a Target for Chemosensitization of
Platinum Resistant Ovarian Cancer cells |
|
05:15
05:45
p.m. |
Gali
Pavlova
SL-24
Induction of neutral
differentiation of Mammalian Adipose Stem Cells (ACSCs), and the Cell
Behavior after Transplantation into Mouse Brain |
05:05
05:25
p.m. |
Eckhard
Thiel
SL-25
Combined
Systemic and Intrathecal Chemotherapy Followed by
high-dose Chemotherapy for CNS Relapse of Aggressive Lymphomas: A Curative
Approach? |
04:55
05:25
p.m. |
Sarwat
Sultana
IL-26
Chrysin
Protects Against Cisplatin-induced Colon Toxicity
via Amelioration of Oxidative Stress and Apoptosis: Probable Role of p38MAPK
and p53 |
05:15
05:35
p.m. |
Nooshin
Bagherani (2)
SL-27
The
Newest Hypothesis about Vitiligo Most of the
Suggested Pathogeneses of Vitiligo can be
attributed to Lack of one Factor: Zinc a2-glycoprotein |
04:45
05:05
p.m. |
Yinhua Yu
SL-28
Corilagin is
the Major Active Compound from Phyllanthus niruri L. Extracts with Antitumor Activities in
Hepatocellular Carcinoma
|
|
Conference Social Mixer: 5:45 – 6:45 p.m.
The buses will leave for hotels at 6:45
p.m.
|
|
第2天:2012年2月13日,星期一 |
|
PLENARY SESSION |
|
Time |
Chairman: H. Michel
Co-Chairman: M. Molina
|
Speaker |
Title |
|
09:00
09:45
a.m. |
Location:
Auditorium |
Robert
Huber (Nobel Laureate)
PL-29 |
Intracellular Proteolysis,
Structures, Mechanisms, and Drug Design |
|
09:45
10:30
a.m. |
Location: Auditorium |
Harald zur Hausen (Nobel Laureate)
PL-30 |
Preventive
Vaccination Against Cancers Caused by Infections
|
|
COFFEE
BREAK: 10:30 – 11:15 a.m. |
|
|
Lecture
Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250)
|
Hall No. 4
(C-106)
|
Hall No. 5
(B-116)
|
|
|
Drug
Metabolism |
CNS
Drug Discovery & Therapy / Hot
Topics in HIV Research |
Cardiovascular
Drug Discovery & Therapy / Proteomics
& Bioinformatics / Structural
Biology / |
Innovative
Drug Discovery & Nanotechnology/ Recent
Advances in Spectroscopy |
Anti-Cancer
Drug Discovery & Therapy |
|
|
Chairman:
A. Claudio Tedesco
Co-Chairman:
M. E. Lamas |
Chairman:
H. Itoh
Co-Chairman:
Y. Suzuki |
Chairman:
T. K. Chakraborty
Co-Chairman:
S. Chandrasekhar |
Chairman:
E S.-Jankun
Co-Chairman:
W. A. Houry |
Chairman: O. Larsson
Co-Chairman:
E. Hadchity |
|
11:15
11:50
a.m. |
C.
Prakash
SIL-31
Mechanism
of Drug Toxicity and Relevance to Pharmaceutical Development |
11:15
11:45
a.m. |
Atsushi Koito
IL-32
Intrinsic
Restriction Activity by APOBEC Enzymes Against HIV and Retroelement |
11:15
11:45
a.m. |
Tamer
Elbayoumi
IL-33
Mitochondria-specific
Nano-Emulsified Therapy for Cardiovascular Protection Against
Doxorubicin-induced Oxidative and Non-Oxidative Toxicities |
11:15
11:45
a.m. |
Martin
J. Korbling
IL-34
Potential
Removal of Circulating Tumor Cells by Photothermoablation
Using Gold-Nanoparticle Constructs |
11:15
11:45
a.m. |
William
B. Weglicki
IL-35
Neurogenic
Inflammation and Cardiac Dysfunction due to Hypomagnesemia
During EGFR-Tyrosine Kinase Inhibition |
|
11:50
12:20
p.m. |
Suresh
Balani
IL-36
Anticipated
Key Changes in the FDA’s Draft DDI Guidance, and Emerging Differences |
11:45
12:15
p.m. |
Hiroshi
Ohrui
IL-37
Development of Modified
Nucleosides that have Extremely High Anti-HIV Activity and Low Toxicity and
Prevent the Emergence of Resistant HIV mutants, and a proposed structure of
Modified Nucleoside Expected to have High Antiviral Activity and Low Toxicity |
11:45
12:15
p.m. |
Dipak
P. Ramji
IL-38
Cytokines,
Macrophages and Atherosclerosis
|
11:45
12:15
p.m. |
Louis
X. Tiefenauer
IL-39
Membrane
Proteins in Stable Lipid Bilayers for Functional Studies and Applications |
11:45
12:15
p.m. |
Theresia Thalhammer
IL-40
Expression
of Transport Proteins from the OATP Family in Solid Tumors: Potential Targets
for Tumor Therapy |
|
12:20
12:50
p.m. |
Mehran
Moghaddam
IL-41
Discovery
of CC-930, An Orally Active Anti-Fibrotic JNK Inhibitor |
12:15
12:45
p.m. |
Chatchai
Tayapiwatana
IL-42
Zinc
Finger Protein Designed to Target 2-LTR-Circle Junctions Interferes with HIV
Integration |
12:15
12:45
p.m. |
Issac
C. Sanchez
IL-162
Introducing
Computational Structural Spectroscopy of Globular Proteins |
12:15
12:45
p.m. |
Roland
H. Stauber
IL-44
Proteomic
Profiling of the Dynamic Nanoparticle-Serum Protein Corona – Implications for
Biomedical Applications |
12:15
12:45
p.m. |
Caroline
van Haften
IL-45
A
new Anti-Cancer Drug Against Ovarian Cancer |
|
12:50
01:20
p.m. |
Lawrence
Gan
IL-46
Discovery
Developability Assessment – a DMPK Perspective |
12:45
01:15
p.m. |
Jamil
S. Saad
IL-47
Structural
Biology of HIV-Host Interactions: Basis for Therapeutic Intervention |
12:45
01:05
p.m. |
Janos
Posfai (2)
SL-48
Domain
Fusions in Restriction-Modification System Enzymes and Genomic Contexts of
Fusions |
12:45
01:05
p.m. |
Sergey
Tarasov
SL-49
Advantages
of Using Antibodies in Ultra Low Doses as a New Pharmacological Approach |
12:45
01:15
p.m. |
Ahcene Boumendjel
IL-50
Inhibitors
of the Multidrug BCRP Transporter: Design, Synthesis, invitro and In vivo Validation |
|
01:20
01:50
p.m. |
Michael
W. Sinz
IL-51
An IGF-IR inhibitor induces
CYP3A4 Expression Through a PXR-independent, non-canonical CAR-related
Mechanism |
01:15
01:45
p.m. |
H.C.
Pant
IL-52
TFP5:
A Peptide Derived from the Cdk5 Regulator p35, Crosses Blood Brain Barrier
and Resources Phenotypes of AD Model mice
|
01:05
01:25
p.m. |
Raul Cavalcante
Maranhao
SL-53
Association
of etoposide to Cholesterol-rich Nanoemulsions Reduces Atherosclerotic Lesions in Rabbits:
A Novel Drug Targeting-based Strategy for the Treatment of Cardiovascular
Disease |
01:05
01:35
p.m. |
Vladimir
V. Tsukruk
IL-74
Label-free
Raman Mapping of Surface Distribution of Protein A and lgG
biomolecules and Selected Biomarkers
|
01:15
01:45
p.m. |
Fazlul Huq
IL-55
Platinum
Resistance in Ovarian Cancer and the Ways to Overcome it
|
|
LUNCH
BREAK: 01:50 – 02:45 p.m. |
|
|
Lecture Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250)
|
Hall No. 4
(C-106)
|
Hall No. 5
(B-116)
|
|
|
Drug
Metabolism |
CNS
Drug Discovery & Therapy / Medical
Imaging |
Cardiovascular
Drug Discovery & Therapy / |
Drug
Discovery in Preclinical Research / Hot
Topics in Natural Products / Anti-Infectives |
Anti-Cancer
Drug Discovery & Therapy |
|
|
Chairman: C. Prakash
Co-Chairman: A. Kamel |
Chairman:
I.M.-Jung
Co-Chairman:
Z. Helyes |
Chairman:
C. A.-Blais
Co-Chairman:
R.-P. Muelle |
Chairman:
R. Chaguturu
Co-Chairman:D.P. Ramji |
Chairman:
M.I.Choudhary
Co-Chairman:
T. A. Tel |
|
02:45
03:15
p.m. |
Shawn
Harriman
IL-56
Using
PK/PD to Define Target Profile Earlier During Drug Discovery |
02:45
03:05
p.m. |
Youssef
Sari
SL-57
Glutamate
Transporter 1: Potential Target for the Treatment of Drug Abuse and
Neurodegenerative Diseases |
02:45
03:05
p.m. |
Mikhail Rudenko
SL-58
New
Method for Monitoring the Effectiveness of Drugs Impact on Cardiovascular
System |
02:45
03:05
p.m. |
Predrag
Novak
SL-59
How
do Macrolide Antibiotics Interact with Bacterial Ribosomes? |
02:45
03:05
p.m. |
Riyaz Basha
SL-60
Towards
Improving Therapeutic Response in Pancreatic Cancer |
|
03:15
03:35
p.m. |
Subrahamanyam
Vangala
SL-61
Drug
Discovery Research: Integrating Medicinal Chemistry, Computational Modeling
Pharmacology, DMPK and Toxicology |
03:05
03:25
p.m. |
Vesna Radojevic
SL-62
Somatostatin
in Mammalian Cochlea: It is a Potential Therapeutic with Protective Effect on
Cochlea |
03:05
03:25
p.m. |
Moses
Kayode Omole
SL-63
Knowledge
of Disease and Adherence to Drug Therapy in Persons with Type 2 Diabetes and
Hypertension |
03:05
03:25
p.m. |
A.
Manaf Ali
SL-64
In-Vivo
Antileukemic Activity of Goniothalamin |
03:05
03:25
p.m. |
Sadanori
Takeo
SL-65
Feasibility
Study for Biweekly Administration of Cisplatin Plus
Vinorelbine as Adjuvant-Chemotherapy for Completely
Resected Non-small Cell Lung Cancer Patients in a Japanese Population |
|
03:35
03:55
p.m. |
Charles
Crespi
SL-66
Efficient
Testing for Metabolism-based DDIs in Drug Discovery and the Implications for
Concordance with Mandated Assay Metbodologies used
in Drug Development |
03:25
03:45
p.m. |
Razia Khanam
SL-67
Evaluation
of Antidepressant Effects of Celecoxib (COX 2
Inhibitor) and its Combination with Duloxetin
(SNRI) in Stressed Mice |
03:25
03:45
p.m. |
Zhangyin
Ming
SL-68
Effects
of Neferine on Platelet Aggregation and
Disaggregation
|
03:25
03:45
p.m. |
Amina
El-Gezeery
SL-69
On
the Protective Effect of Omega-3 Against Propionic Acid-Induced Neurotoxicity
in Rat Pups |
03:25
03:45
p.m. |
Fehmida Fasim
SL-70
Sequence-dependent
Synergism from Combinations of Cisplatin and
Designed Transplatinums in Human Ovarian Tumour Models
|
|
03:55
04:25
p.m. |
Jasminder
Sahi
IL-71
Transporter
Mediated Drug Interactions in Drug Discovery and Development |
03:45
04:05
p.m. |
Marilita
M. Moschos
SL-72
Clinical
Value of Multifocal-Electroretinogram (mf-ERG) in
Retinal Diseases |
03:45
04:05
p.m. |
ALLOTED
FOR CARDIOVASCULAR TRACK
SL-73
TITLE
AWAITED |
03:45
04:05
p.m. |
Faten
Khorshid
SL-74
Tumor
Lung Cancer Model for Assessing Anti-neoplastic Effect of PMF in Rodents: Histopathological Study |
03:45
04:15
p.m. |
Cherng-Chyi Tzeng
SL-75
Design,
Synthesis, and Anticancer Evaluation of Quinoline
Derivatives |
|
04:25
04:45
p.m. |
Emese
Kis
SL-76
In
vitro and invivo Methods to Study Function of Canalicular Efflux Transporters |
04:05
04:25
p.m. |
Marek
Chorazy
SL-77
Study
of Lung Cancer Metastasis to Adrenal Glands and to the Spleen |
04:05
04:25
p.m. |
ALLOTED
FOR CARDIOVASCULAR TRACK
SL-78
TITLE
AWAITED |
04:05
04:35
p.m. |
Youssef
L. Bennani
IL-78
Discovery
and Development of the HCV-Protease Inhibitor: Incivek
|
04:15
04:35
p.m. |
Dipak Panigrahy
SL-80
Epoxy-eicosanoids
Stimulate multi-organ Metastasis and Tumor Dormancy Escape |
|
POSTER PRESENTATION:
04:45 – 6:00 p.m. |
|
Posters Session: 4:45 – 6:00 p.m.
Shopping Tour: Departure at 6:00 p.m.
The buses will leave for hotels at 8:30
p.m.
|
|
第3天:2012年2月14日,星期二 |
|
PLENARY
SESSION |
|
Time |
Chairman: R. Zimmerman
Co-Chairman: G. Mehta |
Speaker |
Title |
|
09:00
09:45
a.m. |
Location: Auditorium |
Ferid
Murad (Nobel Laureate)
PL-81 |
Discovery
of Nitric Oxide and Cyclic GMP Cell Signaling and Their Role in Drug
Development
|
|
09:45
10:30
a.m. |
Location: Auditorium |
Jean-Marie
Lehn (Nobel Laureate)
PL-82 |
From Supramolecular Chemistry towards Adaptive Chemistry Biorganic and Drug Discovery Aspects
|
|
INAUGURAL
CEREMONY OF CURRENT BIOTECHNOLOGY JOURNAL
PUBLISHED BY
BENTHAM SCIENCE PUBLISHERS
10:30 – 10:40 a.m.
COFFEE
BREAK: 10:40 – 11:15 a.m. |
|
|
|
|
Lecture Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250)
|
Hall No. 4
(C-106)
|
|
|
Drug
Metabolism / CNS Drug
Discovery & Therapy / Combinatorial
Chemistry / |
Translational
Medicine |
Recent
Advances in Patient Treatment & Care / Biologics |
Academic
CRO/Industrial Collaborations in Drug Discovery |
|
|
Chairman:
S. Harriman
Co-Chairman:
S. Vangala |
Chairman:
T. Al-Tel
Co-Chairman:
Y.Sari |
Chairman:
M. Rudenko
Co-Chairman:
M. K/Omole |
Chairman:
P. Novak
Co-Chairman:
A. M. Ali |
|
11:15
11:45
a.m. |
Amin Kamel
IL-83
Deuterated
Drug Approach to Mitigate Formation of Reactive Metabolites During Drug
Discovery |
11:15
11:45
a.m. |
Inhee
Mook-Jung
IL-84
Human
Serum Transthyretin Levels Correlate Inversely with
Alzheimer Disease |
11:15
11:45
a.m. |
Chrstiane
Auray-Blais
IL-85
Biomarker
Discovery for Fabry Disease Using a Mass
Spectrometry Approach |
11:15
11:50
a.m. |
R.
Chaguturu
SIL-88
|
|
11:45
12:15
p.m. |
David
M. Stresser
IL-89
Efficient
testing for metabolism-based DDIs in drug discovery and the implications for
concordance with mandated assay methodologies used in drug development |
11:45
12:05
p.m. |
Zsuzsanna
Helyes
SL-90
Pituitary
Adenylate Cyclase-activating
Polypeptide Plays an Important Role in a Mouse Model of Trigeminovascular
Activation |
11:45
12:05
p.m. |
Rolf-Peter
Mueller
SL-91
Intensity
of Combined Modality Chemotherapy and Pet-Guided Radiotherapy in Patients
with Advanced Stage Hodgkin Lymphoma |
11:50
12:20
p.m. |
Dipak
P. Ramji
(2)
IL-99
Atherosclerosis:
Molecular Mechanisms, Therapeutic Targets and Translational Challenges
|
|
12:15
12:35
p.m. |
SL-100
TITLE
AWAITED |
12:05
12:25
p.m. |
Shivendra
V. Singh
SL-95
Prostate
Cancer Prevention with Bioactive Food Components |
12:05
12:25
p.m. |
Alberto
Priori
SL-96
Transcranial
Direct Current Stimulation (tDCS) As Potential
Therapeutic Tools for Neurological and Psychiatric Disorders |
12:20
12:50
p.m. |
Philip
D. Cotter
IL-117
A
New Paradigm for Personalized Medicine and Companion Diagnostics: The
Contract Diagnostics Organization
|
|
12:35
12:55
p.m. |
Moses
Kayode Omol (2)
SL-94
A
survey of Rational Prescriptions of Peniclillin and
Cephalosporin Antibiotics in Sacred Heart Hospita Lantoro Abeokuta in South West Nigeria |
12:25
12:45
p.m. |
Rajesh
Agarwal
SL-101
Targeting
Tumor Microenvironment with Silibinin: Promise and
Potential for a Translational Cancer Chemopreventive
Strategy |
12:25
12:45
p.m. |
Bassam
Alfeeli
SL-102
Toward
Handheld Diagnostics of Cancer Biomarkers in Breath: Microfabricated
Gas Chromatography Systems
|
12:50
01:10
p.m. |
SL-100
TITLE
AWAITED |
|
01:05
01:20
p.m. |
Abdollah
Javidan
SL-186
The
Synthesis of some Tricyclic Benzodiazepinones
|
12:45
01:05
p.m. |
Janos
Posfai
SL-107
Developmental
self Organization and Autism – A Hypothesis |
12:45
01:05
p.m. |
Rakesh
Kumar
IL-143
A
New Role of Endothelin-1 Axis in the Invasiveness of Triple-Negative Breast
Cancer Phenotypes |
01:10
01:30
p.m. |
SL-109
TITLE
AWAITED |
|
LUNCH
BREAK: 01:30 – 2:30 p.m. |
|
|
Lecture Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250)
|
Hall No. 4
(C-106)
|
|
|
Stereoselective
Synthesis of Bioactive Compounds / Neutraceutical
Drug Discovery & Therapy / |
Inflammation
and Immunology / |
Hot
Topics in Medicinal Chemistry / Drug
Delivery & Targeting / Pharmaceutical
Research & Development |
Academic
CRO/Industrial Collaborations in Drug Discovery |
|
|
Chairman:
J. Wu
Co-Chairman:
A. Hamad |
Chairman:
M. Hust
Co-Chairman:
D.K. Lahiri |
Chairman:
S. J. Faulkner
Co-Chairman:
T.-Lin Li |
Chairman:
R. Chaguturu
Co-Chairman:
D. P. Ramji |
|
02:30
03:00
p.m. |
Rodney
A. Fernandes
IL-112
Development
of Dimeric Fischer Carbenes:
A Bidirectional Dotz Benzannulation
Approach to Dimeric Pyranonaphthoquinones
|
02:30
03:00
p.m. |
D.D.
Adams
IL-113
REVISED
TITLE AWAITED |
02:30
03:00
p.m. |
Taleb
H. Al-Tel
IL-114
An
Appraisal for the Development of Therapeutics for Alzheimer’s Disease:
Design, Synthesis and Qualitatve Structure Activity
Evaluations of Novel b-Secretase Inhibitors |
02:30
03:00
p.m. |
IL-109
TITLE
AWAITED |
|
03:00
03:50
p.m. |
Victor
Borovkov
SL-118
Optically
Active Compounds: Supramolecular Absolute Configuration
Determination and Prospects in Stereoselective
Catalysis |
03:00
03:30
p.m. |
Akinori
Takaoka
IL-119
ZAPS
as a Booster of Innate Immune Signaling for Antiviral Defense Against
Influenza Virus Infecton
|
03:00
03:20
p.m. |
Xiang-Qu Xie
SL-120
New
Drug Target and Novel Chemical Agents for Multiple Myeloma Therapeutic
Interventions |
03:00
03:20
p.m. |
SL-109
TITLE
AWAITED |
|
03:50
04:10
p.m. |
Abdollah
Javidan (2)
SL-124
1-Pot
4 Components Reactions for Synthesis of Nove Barbituric Acid Derivatives |
03:30
03:50
p.m. |
Mohamed
Nabih Abdel Rahman
SL-125
Study
of Atorvastatin in Experimental Allergic Airway Inflammation in Mice |
03:20
03:50
p.m. |
Jay
F. Dorsey
IL-126
Enhancing
the Efficacy of Drug-Loaded Nanocarrier (DLN)
Against Brain Tumors by Targeted Radiation Therapy |
03:20
03:50
p.m. |
IL-109
TITLE
AWAITED |
|
04:10
04:40
p.m. |
Debomoy
K. Lahiri
IL-87
Neuroprotective
and Neuropreservative Effects of Nutraceuticals in Neuronal Culture Systems: Potential
Preventive/Therapeutic Strategies in Alzeimer’s
Disease (AD) |
03:50
04:10
p.m. |
Erika
Pinter
SL-131
SST4
Somatostatin Receptor as a Promising Drug Target |
03:50
04:10
p.m. |
Ayman
Allahham
SL-122
Incorporation
of Micronised Poorly Water-Soluble Additive Into
Indomethacin Formulated Tablets.
Effect of Carrier Type, Additive and Drug
|
03:50
04:10
p.m. |
SL-133
TITLE
AWAITED |
|
04:40
05:00
p.m. |
Abdullah
bin Habeeballah bin Abdullah Juma
SL-93
The
Discovery of the Efficacy of Lepidium Sativum Seeds on Fracture Healings |
04:10
04:30
p.m. |
Manal
A. Abd El-Hafez
SL-137
Gene
Polymorphisms of TNF-a and IL-10 related
to Rheumatic Heart Disease |
04:10
04:30
p.m. |
Faten
Khorshid (2)
SL-128
An
Ointment Contain 3% of PMF Components Showed Promisting
Results for Treatment of Psoriasis CASE REPORT |
04:10
04:40
p.m. |
IL-153
TITLE
AWAITED
|
|
POSTER
PRESENTATION: 05:00 – 6:00 p.m. |
|
Posters Session: 5:00 – 6:00 p.m.
Departure for Gala Dinner: Departure at
6:00 p.m.
The buses will leave for hotels at 8:30
p.m.
|
|
第4天:2012年2月15日,星期三 |
|
PLENARY
SESSION |
|
Time |
Chairman: F. Murad
Co-Chairman:
Atta-ur-Rahman
|
Speaker |
Title |
|
09:00 09:45
a.m. |
Location: Auditorium |
Ron Zammerman
PL-148 |
Plx Pharma – Developing A GI
Safer Aspirin
|
|
09:45
10:30
a.m. |
Location: Auditorium |
G. Mehta
PL-149 |
Title: Awaited |
|
|
Lecture Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250) |
Hall No. 4
(C-106) |
|
|
Hot
Topics in Natural Products / Enabling Technologies |
Hot
Topics in Drug Targets / Pharmaceutical
Biotechnology |
Regenerative
Medicine |
|
|
|
Chairman:
S. Sultana
Co-Chairman:
E. Thiel |
Chairman:
M. Ozbilen
Co-Chairman:
E. Thiel |
Chairman:
Y. Yu
Co-Chairman:
M. Wang |
Chairman:
J. F. Dorsey
Co-Chairman:
A. Kopylov |
|
10:40
11:00
a.m. |
Jun
Wu
SL-150
Limonoids
from Mangrove Plants of the Xylocarpus Genus and
Their Bioactivities |
10:40
11:10
a.m. |
Michael
Hust
IL-86
Antibody
Phage Display for Diagnostics and Therapy
|
10:40
11:10
a.m. |
Stephen
J. Faulkner (2)
IL-152
Safety
and Complications Reporting Update on the Re-Implantation of Culture-Expanded
Mesenchymal Stem Cells Using Autologous Platelet Lysate
Technique |
10:40
11:10
a.m. |
IL-153
TITLE
AWAITED |
|
11:00
11:20
a.m. |
Alexey
Kopylov
SL-139
Modular
Construction of Aptameric
Nanostructures: Anti-Thrombin Aptamers |
11:10
11:30
a.m. |
Tsung-Lin
Li
SL-92
Biosynthesis
and Diversification of Lipoglycopeptide Antibiotics
|
11:10
11:40
a.m. |
Aris
Lacis (2)
IL-158
Method
of Choice for Stem Cell Intramyocardial
Implantation in Children |
11:10
11:40
a.m. |
IL-159
TITLE
AWAITED |
|
11:20
11:40
p.m. |
Kam
Y. J. Zhang
SL-145
Scaffold-based Drug
Design: An Efficient Tool for the Discovery of New Molecular Entities |
11:30
11:50
p.m. |
SL-156
TITLE
AWAITED
|
11:40
12:00 |
Abdullah
bin (2)
Habeeballah bin Abdullah Juma
SL-183
A
Very Rare Combination of Nail – Patella Syndrome (NPS) ad Down’s Syndrome
(DS): The First Described Study
|
11:40
12:00 |
SL-156
TITLE
AWAITED
|
|
COFFEE
BREAK: 12:00 – 12:30 a.m. |
|
|
Lecture Hall 1
(L-115) |
Lecture Hall 2
(B-121)
|
Hall No. 3
(B-250)
|
Hall No. 4
(C-106)
|
|
|
Diabetes
& Obesity Drug Discovery & Therapy/ Drug
Discovery in Preclinical Research / Cardiovascular
Drug Discovery & Therapy |
Translational
Medicine / CNS Drug
Discovery & Therapy / Recent
Advances in Patient Treatment & Care / Protein
& Peptie Sciences / Pulmonary Drug Discovery Therapy / Inflammation and Immunology
|
/
Anti-Cancer Drug Discovery &
Therapy / Women’s Health
Drug Discovery & Therapy / |
|
|
|
Chairman:
R. A. Fernandes
Co-Chairman:
V. Borovkov |
Chairman:
M.I. Choudhary
Co-Chairman:
D.D. Adams |
Chairman:
X.-Qu\. Xie
Co-Chairman:
A. Allahham |
Chairman:
Z. Ming
Co-Chairman:
Y. L. Bennani |
|
12:30
01:00
a.m. |
Jerry
Jiayu Liao
IL-98
Small
Molecular Modulators for GLP1 Receptor
|
12:30
01:00
a.m. |
Claudia
Gragnoli
IL-180
Proteasome
Modulator 9 is Linked to Microvascular Pathology of
T2D
|
12:30
01:00
a.m. |
Tamer
Elbayoumi
(2)
IL-170
Novel
Genistein-Loaded Lipidic Nanocarrier Adjuvants Enhance Anticancer Efficacy and Overcome
Cancer Resistance to Chemotherapy |
12:30
01:00
a.m. |
IL-165
TITLE
AWAITED |
|
01:00
01:30
p.m. |
Abdel
Hamad
IL-104
Immunotherapy
for type 1 Diabetes: Necessity, Challenges and Unconventional Opportunities
|
01:00
01:30
noon |
D.D.
Adams (2)
IL-188
The
Essential Role of the Histocompatibity System for
Virus Defence and How Transplant Surgeons can Xenograft Without rejection |
01:00
01:30
p.m. |
Wael M. ElShamy
IL-154
Geminin
Overexpression Induces Imatinib Sensitive Mammary
Tumors via Nuclear C-ABL
|
01:00
01:30
p.m. |
IL-171
TITLE
AWAITED |
|
01:30
01:50
p.m. |
A.
Manaf Ali (2)
SL-169
In-vitro
and In-vivo Antileukemic Activities of New Castle Disease
Virus Strains Af2240 and V4-Upm
|
01:30
01:50
p.m. |
Youssef
Sari (2)
SL-181
Neuroprotective
Peptides Against the Effects of Oxidative Stress |
01:30
01:50
p.m. |
George
Falkay
SL-115
Increased
Tocolytic Effect of Nifedipine
by ABCG2 Efflux Protein Inhibitor KO134 in Rat in vivo |
01:30
02:00
p.m. |
IL-177
TITLE
AWAITED
|
|
01:50
02:10
p.m. |
Basiouny
El-Gamal (2)
SL-175
L-Arginine
Ameliorates Intralipid-induced Dyslipidemia and Hyperglycemia
in Experimental Animals |
01:50
02:10
p.m. |
Mehmet
Ozbilen (2)
SL-187
Systematic
Reviw and Meta-analysis of Anticholinergic Side
Effects of Long-acting antipsychotics |
01:50
02:20
p.m. |
Allan
G.A. Coombes
IL-121
Controlled
Microbicide Delivery Using Intra-vaginal Polymeric
Matrices |
02:00
02:20
p.m. |
SL-199
TITLE
AWAITED
|
|
02:10
02:40
p.m. |
Claudia
Gragnoli (2)
IL-164
Proteasome
Modulator 9 and Depression |
02:10
02:30
p.m. |
Jerzy Jankun
SL-103
Plasminogen
Activator Inhibitor with very Long Half-Life (VLHL PAI-1) in Cancer, PAI-1
Deficiency and Diabetes Therapy
|
02:20
02:40
p.m. |
Shao-fen
Zhang
SL-127
Clinical
Research on Gonadotropin Releasing Hormone Analogue and Estrogen-progestogen Add-back Therapy in the Treatment of
Endometriosis |
02:00
02:40
p.m. |
SL-189
TITLE
AWAITED |
|
02:40
03:00
p.m. |
Mikhail
Rudenko (2)
SL-182
Phase
Hemodynamic Parameters Measuring for Monitoring the Treatment Effectiveness on
Cardiovascular System |
02:30
02:50
p.m. |
Y.S.
Prakash
SL-168
Sex
Steroids in Asthma
|
02:40
03:00
p.m. |
SL-195
TITLE
AWAITED |
02:40
03:00
p.m. |
SL-195
TITLE
AWAITED |
|
LUNCH
BREAK: 03:00 – 04:00 p.m.
POSTER PRESENTATIONS:
04:00 – 4:45 p.m.
CASH PRIZE
ANNOUNCEMENT FOR THREE BEST POSTERS: 4:45 p.m.
POSTER
PRESENTER’S PRESENCE IS ESSENTIAL TO RECEIVE THE CASH AWARD AND CERTIFICATE
OF MERIT |
|
Posters Session: 04:00 – 4:45 p.m.
City Tour: Departure at 5:00 p.m.
IMPORTANT: The buses will leave daily from all Hotels
at 8:15 a.m. for the conference venue.
PL: Plenary Lecture
SIL: Special Invited Lecture
IL: Invited Lecture
SL: Session Lecture |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
